Effects of long-term sustained naltrexone release on the optic center in opioid-dependent patients: Case-control study in four provinces of China

Neural Regeneration Research

Volumn 6, Issue 3, 2011, Pages 236-240

  He, Shengxi ^a,b   Yu, Longchuan ^b   Jia, Shaowei ^a   Chen, Qing ^a   Wang, Dongmei ^c   Hu, Shu ^a  

^a PEKING UNIVERSITY SHENZHEN HOSPITAL   (China)

^b PEKING UNIVERSITY   (China)

^c INSTITUTE OF PSYCHOLOGY   (China)

Author keywords

Event related potential; Long term sustained naltrexone release; Opioid dependence; P100; Projection of unilateral visual field

Indexed keywords

METHADONE; MORPHINE; NALTREXONE; OPIATE; PROTEIN P100;

ADULT; ARTICLE; CONTROLLED STUDY; DETOXIFICATION; ELECTRODE; EVENT RELATED POTENTIAL; HUMAN; LATENT PERIOD; MAJOR CLINICAL STUDY; MALE; OPIATE ADDICTION; REACTION TIME; RIGHT HANDEDNESS; SIGNAL TRANSDUCTION; SUSTAINED DRUG RELEASE; VISUAL FIELD; VISUAL NERVOUS SYSTEM;

EID: 79951705469     PISSN: 16735374     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.1673-5374.2011.03.013     Document Type: Article

References (36)

1. Gary KH, Robert JT, Sandra DC, et al. Reducing hospital presentations for opioid overdose in patients treated with sustained release naltrexone implants. Drug Alcohol Depend. 2005;79(3): 351-357.
2. O'Brien CP. Anticraving medications for relapse prevention: A possible new class of psychoactive medications. Am J Psychiatry. 2005;162:1423-1431.
3. Wang YC, Jiao SL, Liu L. The effect of rapid detoxification with naltrexone suppository embedment for heroin dependence. Zhongguo Yaowu Yilaixing Zazhi. 2007;16(2):114-117.
4. He SX, Yu LC, Jia SW, et al. Cue-elicited event-related potential evaluation of long-term sustained release naltrexone treatment for opioid dependence. Zhongguo Zuzhi Gongcheng Yanjiu yu Linchuang Kangfu. 2008;12(1):47-50.
5. Comer SD, Sullivan MA, Hulse GK. Sustained-release naltrexone: novel treatment for opioid dependence. Expert Opin Investig Drugs. 2007;16(8):1285-1294.
6. Roozen HG, de Waart R, van der Windt DA, et al, A systematic review of the effectiveness of naltrexone in the maintenance treatment of opioid and alcohol dependence. Eur Neuropsychopharmacol. 2006;16(5):311-323.
7. He SX, Yu LC, Jia SW, et al. Cue-elicited event-related potential evaluation of long-term sustained release naltrexone treatment for opioid dependence. Zhongguo Zuzhi Gongcheng Yanjiu yu Linchuang Kangfu. 2008;12(6):1027-1030.
8. He SX, Yu LC, Jia SW, et al. The ERP study on the effective of LSRNTX treatment for opioid dependences on their emotion. Zhongguo Xingwei Yixue Kexue. 2008;17(9):796-798.
9. He SX, Yu LC, Jia SW, et al. Effects of long-term sustained release naltrexone treatment on image racognition in patients with opioid dependence: an ERP study. Zhongguo Xinli Weisheng Zazhi. 2009; 1(1):5-9.
10. He SX, Yu LC, Jia SW, et al. Effect of long-term sustained release naltrexone on semantic recognition of opioid addicts. Zhongguo Zuzhi Gongcheng Yanjiu yu Linchuang Kangfu. 2009;13(8): 1573-1576.
11. Maurage P, Philippot P, Joassin F, et al. The auditory-visual integration of anger is impaired in alco-holism: an event-related potentials study. J Psychiatry Neurosci. 2008;3(2):111-122.
12. Maurage P, Philippot P, Campanella S, et al. Is the P300 deficit in alcoholism associated with early visual impairments (P100, N170)? An oddball paradigm. Clin Neurophysiol. 2007;118(3):633-644.
13. Wegner AJ, Günthner A, Fahle M. Visual performance and recovery in recently detoxified alcoholics. Alcohol Alcohol. 2001;36(2): 171-179.
14. Chan YW, McLeod JG, Tuck RR, et al. Visual evoked responses in chronic alcoholics. J Neurol Neurosurg Psychiatry. 1986;49(8): 945-950.
15. Lingford-Hughes A. Human brain imaging and substance abuse. Curr Opin Pharmacol. 2005;5(1):42-46.
16. Moselhy HF, Georgiou G, Kahn A. Frontal lobe changes in alcoholism: a review of the literature. Alcohol Alcohol. 2001;36(5): 357-368.
17. Lee TM, Zhou WH, Luo XJ, et al. Neural activity associated with cognitive regulation in heroin users: A fMRI study. Neurosci Lett. 2005;382(3):211-216.
18. Wei B, Zhou ES, Tian DW. The observed on the effective of heroin on vision. Huazhong Yixue Zazhi. 2005;29(6):469-470.
19. Jääskeläinen IP, Hirvonen J, Kujala T, et al. effects of naltrexone and ethanol on auditory event-related brain potentials. Alcohol. 1998;15(2):105-111.
20. Kenny PJ. Brain reward systems and compulsive drug use. Trends Pharmacol Sci. 2007;28(3):135-141.
21. Bauer LO. CNS recovery from cocaine, cocaine and alcohol, or opioid dependence: a P300 study. Clin Neurophysiol. 2001;112 (8):1508-1515.
22. Aron JL, Paulus MP. Location, location: using functional magnetic resonance imaging to pinpoint brain differences relevant to stimulant use. Addiction. 2007;102(Suppl 1):33-43.
23. Attou A, Figiel C, Timsit-Berthier M. Opioid addiction: P300 assessment in treatment by methadone substitution. Neurophysiol Clin. 2001;31(3):171-180.
24. Franken IH, Stam CJ, Hendriks VM, et al. Neurophysiological evidence for abnormal cognitive processing of drug cues in heroin dependence. Psycho-pharmacology (Berl). 2003;170(2):205-212.
25. Bauer LO. Effects of chronic opioid dependence and HIV-1 infection on pattern shift visual evoked potentials. Drug Alcohol Depend. 1998;50(2):147-155.
26. Zhang CY, He CZ, Tian Y. Preliminary study on cognitive potential P300 in heroin addicts. Zhongguo Yaowu Yilaixing Zazhi. 2000;9(4): 4-5.
27. Patrick GO, David AF. Pharmacologic treatment of heroindependent patients. Ann Intern Med. 2000;133(1):40-54.
28. Herbert DK. Future advances in addiction treatment. Clin Neurosci Res. 2005;5(2):201-205.
29. Dayas CV, Liu X, Simms CV, et al. Distinct patterns of neural activation associated with ethanol seeking: effects of naltrexone. Biol Psychiatry. 2007;61(8):979-989.
30. O'Brien CP. Anticraving medications for relapse prevention: A possible new class of psychoactive medications. Am J Psychiatry. 2005;162(8):1423-1431.
31. Minozzi S, Amato L, Vecchi S, et al. Oral naltrexone maintenance treatment for opioid dependence. Cochrane Database Syst Rev. 2006;(1):CD001333.
32. Van Bockstaele EJ, Rudoy C, Mannelli P, et al. Elevated mu-opioid receptor expression in the nucleus of the solitary tract accompanies attenuated withdrawal signs after chronic low dose naltrexone in opiate-dependent rats. J Neurosci Res. 2006;83(3):508-514.
33. State Council of the People's Republic of China. Administrative Regulations on Medical Institution. 1994.
34. rd ed. Jinan: Shandong Science and Technology Press. 2006.
35. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Washington, DC: APA Press. 1994.
36. He SX,Yang ZW, Yin WG. Chinese children developmental dyslexia: a visual event related potential study. Zhongguo Xingwei Yixue Kexue. 2008;17(2):174-176.